296 related articles for article (PubMed ID: 31172494)
21. Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications.
Tarazona-Santos E; Machado M; Magalhães WC; Chen R; Lyon F; Burdett L; Crenshaw A; Fabbri C; Pereira L; Pinto L; Redondo RA; Sestanovich B; Yeager M; Chanock SJ
Mol Biol Evol; 2013 Sep; 30(9):2157-67. PubMed ID: 23821607
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
[TBL] [Abstract][Full Text] [Related]
23. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
24. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
[TBL] [Abstract][Full Text] [Related]
25. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.
Meissner F; Seger RA; Moshous D; Fischer A; Reichenbach J; Zychlinsky A
Blood; 2010 Sep; 116(9):1570-3. PubMed ID: 20495074
[TBL] [Abstract][Full Text] [Related]
26. Chronic granulomatous disease.
Roos D
Br Med Bull; 2016 Jun; 118(1):50-63. PubMed ID: 26983962
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation in EROS (CYBC1) causes chronic granulomatous disease.
Mortimer PM; Nichols E; Thomas J; Shanbhag R; Singh N; Coomber EL; Malik TH; Pickering MC; Randzavola L; Rae W; Bhattad S; Thomas DC
Clin Immunol; 2023 Oct; 255():109761. PubMed ID: 37673227
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.
Akar HT; Esenboga S; Cagdas D; Halacli SO; Ozbek B; van Leeuwen K; de Boer M; Tan CS; Köker Y; Roos D; Tezcan I
J Clin Immunol; 2021 Jul; 41(5):992-1003. PubMed ID: 33629196
[TBL] [Abstract][Full Text] [Related]
30. The phagocyte respiratory burst: Historical perspectives and recent advances.
Thomas DC
Immunol Lett; 2017 Dec; 192():88-96. PubMed ID: 28864335
[TBL] [Abstract][Full Text] [Related]
31. De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.
Yu L; Li W; Lv G; Sun G; Yang L; Chen J; Zhou L; Ding Y; Zhang Z; Tang X; An Y; Zhao X
J Clin Immunol; 2023 Jan; 43(1):88-100. PubMed ID: 35997928
[TBL] [Abstract][Full Text] [Related]
32. The phagocyte NOX2 NADPH oxidase in microbial killing and cell signaling.
Nauseef WM
Curr Opin Immunol; 2019 Oct; 60():130-140. PubMed ID: 31302569
[TBL] [Abstract][Full Text] [Related]
33. [Bacillus Calmette-Guérin infection and chronic granulomatous disease due to new pathogenic variants in the NCF2 gene in the Mayan ethnic group. Report of two cases.].
Peñafiel-Vicuña AK; Coyata-Guzmán R; González Reynoso A; Palma-Chan AG; Baeza-Bastarrachea R; García-Ruelas SA; Costta-Michuy Á; Razo-Requena C; León-Lara X; Espinosa-Padilla S; Espinosa-Rosales F; Bustamante J; Blancas-Galicia L
Rev Alerg Mex; 2023 Apr; 69(4):220-227. PubMed ID: 37218049
[TBL] [Abstract][Full Text] [Related]
34. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
Kutukculer N; Aykut A; Karaca NE; Durmaz A; Aksu G; Genel F; Pariltay E; Cogulu Ö; Azarsız E
Scand J Immunol; 2019 Feb; 89(2):e12737. PubMed ID: 30506560
[TBL] [Abstract][Full Text] [Related]
35. Activation of cryptic splice sites in three patients with chronic granulomatous disease.
de Boer M; van Leeuwen K; Hauri-Hohl M; Roos D
Mol Genet Genomic Med; 2019 Sep; 7(9):e854. PubMed ID: 31364312
[TBL] [Abstract][Full Text] [Related]
36. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.
Muise AM; Xu W; Guo CH; Walters TD; Wolters VM; Fattouh R; Lam GY; Hu P; Murchie R; Sherlock M; Gana JC; ; Russell RK; Glogauer M; Duerr RH; Cho JH; Lees CW; Satsangi J; Wilson DC; Paterson AD; Griffiths AM; Silverberg MS; Brumell JH
Gut; 2012 Jul; 61(7):1028-35. PubMed ID: 21900546
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
38. Phagocyte NADPH oxidase and specific immunity.
Cachat J; Deffert C; Hugues S; Krause KH
Clin Sci (Lond); 2015 May; 128(10):635-48. PubMed ID: 25760962
[TBL] [Abstract][Full Text] [Related]
39. Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes.
Luengo-Blanco M; Prando C; Bustamante J; Aragão-Filho WC; Pereira PV; Rehder J; Padden C; Casanova JL; Newburger PE; Condino-Neto A
Blood; 2008 Aug; 112(4):1453-60. PubMed ID: 18523147
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
